Phage-Mediated Gene Therapy

Current Gene Therapy
Zeinab Hosseinidoust

Abstract

Bacteriophages (bacterial viruses) have long been under investigation as vectors for gene therapy. Similar to other viral vectors, the phage coat proteins have evolved over millions of years to protect the viral genome from degradation post injection, offering protection for the valuable therapeutic sequence. However, what sets phage apart from other viral gene delivery vectors is their safety for human use and the relative ease by which foreign molecules can be expressed on the phage outer surface, enabling highly targeted gene delivery. The latter property also makes phage a popular choice for gene therapy target discovery through directed evolution. Although promising, phage-mediated gene therapy faces several outstanding challenges, the most notable being lower gene delivery efficiency compared to animal viruses, vector stability, and nondesirable immune stimulation. This review presents a critical review of promises and challenges of employing phage as gene delivery vehicles as well as an introduction to the concept of phage-based microbiome therapy as the new frontier and perhaps the most promising application of phage-based gene therapy.

Citations

Jul 17, 2020·Frontiers in Cell and Developmental Biology·Waseem Akram MallaAshok Kumar Tiwari
Jul 3, 2021·Pharmaceuticals·Bryan GibbChristine L Schneider

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Expert Opinion on Drug Delivery
Iftach Yacoby, Itai Benhar
Biological Reviews of the Cambridge Philosophical Society
M DELBRUCK
Current Pharmaceutical Biotechnology
D LaroccaAndrew Baird
© 2022 Meta ULC. All rights reserved